Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06553898 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

StatusRecruiting
PhasePhase 1
Started2024-08-13
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 29, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-08-28
Study Status, Oversight v2
Primary completion date2025-07-31→2026-07-31
2024-11-11
Study Status v1
Re-verified, no change to tracked fields
2024-08-12
Original filing
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-BCMA/CD70 CAR-T cells in the treatment of patients with Multi-drug resistant SRNS
Trial Details
NCT Number NCT06553898
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy
Enrollment 18 participants
Start Date 2024-08-13
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-29